Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study.

Maximum utilization of the life table method in analyzing survival

1958 • 2,937 citations

Assessment of response to therapy in advanced breast cancer

1977 • 705 citations

4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER

1984 • 235 citations

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

1987 • 234 citations

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.

1986 • 211 citations

Aromatase activity in primary and metastatic human breast cancer

1987 • 137 citations

4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer

1987 • 79 citations

Aminoglutethimide in the treatment of advanced breast cancer

1984 • 63 citations

Aromatase inhibitors, their pharmacology and application

1983 • 39 citations

Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.

1986 • 18 citations